1822-P: Pharmacokinetic and Pharmacodynamic Profiles of GZR102 Injection, a Novel Once-Weekly Fixed-Ratio Combination of Insulin GZR4 and GLP-1 Analog Bofanglutide
YAN HUANG, Anshun He, Wancai Xing, TIAN XIE et autres
Introduction and Objective: GZR102 injection (GZR102) is a novel once-weekly fixed-ratio combination (FRC) of insulin GZR4 and the GLP-1 analog bofanglutide (GZR18). GZR102 is designed to preserve the pharmacokinetic (PK) characteristics of the individual components while delivering complementary glycemic control and metabolic …
us (code pays fourni par la source)
0 citations
Diabetes